These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1854173)
21. A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental legionellosis in guinea pigs. García-de-Lomas J; Millás E; Lázaro MA; Bermejo M; Gimeno C; Navarro D; Sánchez S Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):420-3. PubMed ID: 9758285 [TBL] [Abstract][Full Text] [Related]
23. Combined therapy with co-amoxiclav and erythromycin against intracellular Legionella pneumophila in cell culture and in an experimental respiratory infection in neutropenic rats. Smith GM; Abbott KH; Beale AS J Antimicrob Chemother; 1995 Jun; 35(6):889-93. PubMed ID: 7559201 [No Abstract] [Full Text] [Related]
24. The effect of antibiotics on the growth of Legionella pneumophila in guinea-pig alveolar phagocytes infected in vivo by an aerosol. Fitzgeorge RB J Infect; 1985 May; 10(3):189-93. PubMed ID: 3161953 [TBL] [Abstract][Full Text] [Related]
25. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. Edelstein PH; Shinzato T; Doyle E; Edelstein MA Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675 [TBL] [Abstract][Full Text] [Related]
26. In vitro activity of macrolides against intracellular Legionella pneumophila. Segreti J; Meyer P; Kapell K Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407 [TBL] [Abstract][Full Text] [Related]
27. In vivo activity of amoxicillin/clavulanic acid and erythromycin in experimental otitis media caused by Streptococcus pneumoniae plus Haemophilus influenzae. Parra A; Ponte C; Cenjor C; García-Olmos M; Giménez MJ; Aguilar L; Soriano F Int J Antimicrob Agents; 2004 Jan; 23(1):25-31. PubMed ID: 14732310 [TBL] [Abstract][Full Text] [Related]
28. In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia. Edelstein PH; Higa F; Edelstein MA Antimicrob Agents Chemother; 2001 Oct; 45(10):2685-90. PubMed ID: 11557455 [TBL] [Abstract][Full Text] [Related]
37. Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection. Vallée E; Azoulay-Dupuis E; Swanson R; Bergogne-Bérézin E; Pocidalo JJ J Antimicrob Chemother; 1991 Feb; 27 Suppl A():31-41. PubMed ID: 1827100 [TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo antibacterial activities of clarithromycin. Ono T; Numata K; Nagate T; Mitsuhashi S; Inoue M Chemotherapy; 1996; 42(3):159-69. PubMed ID: 8983882 [TBL] [Abstract][Full Text] [Related]
39. Chemical modification of erythromycins. III. In vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycins A, TE-031 (clarithromycin) and TE-032. Morimoto S; Nagate T; Sugita K; Ono T; Numata K; Miyachi J; Misawa Y; Yamada K; Omura S J Antibiot (Tokyo); 1990 Mar; 43(3):295-305. PubMed ID: 2139023 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and antibacterial activity of a novel series of acylides: 3-O-(3-pyridyl)acetylerythromycin A derivatives. Tanikawa T; Asaka T; Kashimura M; Suzuki K; Sugiyama H; Sato M; Kameo K; Morimoto S; Nishida A J Med Chem; 2003 Jun; 46(13):2706-15. PubMed ID: 12801234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]